Rod Kunynetz

The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring

Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis

Neutralization of IL-17 ameliorates uveitis but damages photoreceptors in a murine model of spondyloarthritis

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial

New insights into T cell biology and T cell‐directed therapy for autoimmunity, inflammation, and immunosuppression

Psoriasis

Hidradenitis suppurativa: A comprehensive review

The pro- and anti-inflammatory properties of the cytokine interleukin-6

Ustekinumab: Lessons Learned from Targeting Interleukin‐12/23p40 in Immune‐Mediated Diseases

The Pathogenesis of Rheumatoid Arthritis

IL-6 as a keystone cytokine in health and disease

Immune attack: the role of inflammation in Alzheimer disease

Psoriasis

The JAK/STAT signaling pathway: from bench to clinic

Chronic inflammatory diseases: Do immunological patterns drive the choice of biotechnology drugs? A critical review

Peritoneal tuberculosis in the setting of ustekinumab treatment for psoriasis

Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis

Acne vulgaris

Managing comorbid disease in patients with psoriasis

Inflammation and Bone Destruction in Arthritis: Synergistic Activity of Immune and Mesenchymal Cells in Joints

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis

Averting inflammation by targeting the cytokine environment

An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: Assessment of efficacy and safety in 2813 patients

PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis

Functional Specialization of Interleukin-17 Family Members

Guidelines of care for the management of psoriasis and psoriatic arthritis

10 Years of GWAS Discovery: Biology, Function, and Translation

Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: a randomized, placebo-controlled, phase II trial

Treatment of acne with topical antibiotics: lessons from clinical studies

Macrophage Cytokines: Involvement in Immunity and Infectious Diseases

Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial

Investigation of the relationship between the onset of arthritis and uveitis in genetically predisposed SKG mice

Nrf2 activation improves experimental rheumatoid arthritis

Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review.

T‐cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man

Antidrug antibodies in psoriasis: a systematic review

Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints

Psoriasis Pathogenesis and Treatment

Immunology of Psoriasis

Nanotechnology for Multimodal Synergistic Cancer Therapy

Effect of Impaired T Cell Receptor Signaling on the Gut Microbiota in a Mouse Model of Systemic Autoimmunity

Second malignancies in cutaneous T cell lymphoma

Interleukin‐23 Mediates the Intestinal Response to Microbial β‐1,3‐Glucan and the Development of Spondyloarthritis Pathology in SKG Mice

Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease

Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine

Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics

ZAP‐70 Genotype Disrupts the Relationship Between Microbiota and Host, Leading to Spondyloarthritis and Ileitis in SKG Mice

Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis

Pathophysiology, Clinical Presentation, and Treatment of Psoriasis

IL12/23 p40 Inhibition Ameliorates Alzheimer's Disease-Associated Neuropathology and Spatial Memory in SAMP8 Mice

Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial

A Randomized, Double-Blind, Multicenter, Parallel Group Study to Compare Relative Efficacies of the Topical Gels 3% Erythromycin/5% Benzoyl Peroxide and 0.025% Tretinoin/Erythromycin 4% in the Treatment of Moderate Acne Vulgaris of the Face

A Randomized, Double-Blind, Multicenter, Parallel Group Study to Compare Relative Efficacies of the Topical Gels 3% Erythromycin/5% Benzoyl Peroxide and 0.025% Tretinoin/Erythromycin 4% in the Treatment of Moderate Acne Vulgaris of the Face

The occurrence of mycosis fungoides in two patients with preexisting Hodgkin's disease.